MARC details
| 000 -LEADER |
|---|
| fixed length control field |
03592nam a22005177a 4500 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
221213s20222022 xxu||||| |||| 00| 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER |
|---|
| International Standard Serial Number |
1878-0938 |
| 024 ## - OTHER STANDARD IDENTIFIER |
|---|
| Standard number or code |
10.1016/j.carrev.2022.10.007 [doi] |
| 024 ## - OTHER STANDARD IDENTIFIER |
|---|
| Standard number or code |
S1553-8389(22)00825-9 [pii] |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
Ovid MEDLINE(R) |
| 099 ## - LOCAL FREE-TEXT CALL NUMBER (OCLC) |
|---|
| PMID |
36347732 |
| 245 ## - TITLE STATEMENT |
|---|
| Title |
Impact of close surveillance on dual-antiplatelet therapy compliance in myocardial infarction patients post-percutaneous coronary intervention. |
| 251 ## - Source |
|---|
| Source |
Cardiovascular Revascularization Medicine. 2022 Oct 21 |
| 252 ## - Abbreviated Source |
|---|
| Abbreviated source |
Cardiovasc Revasc Med. 2022 Oct 21 |
| 253 ## - Journal Name |
|---|
| Journal name |
Cardiovascular revascularization medicine : including molecular interventions |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. |
|---|
| Year |
2022 |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. |
|---|
| Manufacturer |
FY2023 |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. |
|---|
| Publication date |
2022 Oct 21 |
| 265 ## - SOURCE FOR ACQUISITION/SUBSCRIPTION ADDRESS [OBSOLETE] |
|---|
| Publication status |
aheadofprint |
| 266 ## - Date added to catalog |
|---|
| Date added to catalog |
2022-12-13 |
| 501 ## - WITH NOTE |
|---|
| Local holdings |
Available in print through MWHC library: 2002 - present |
| 520 ## - SUMMARY, ETC. |
|---|
| Abstract |
BACKGROUND: Dual-antiplatelet therapy (DAPT) with aspirin and a P2Y12 receptor inhibitor is the mainstay regimen for acute coronary syndrome (ACS) patients after percutaneous coronary intervention (PCI). We aimed to investigate DAPT compliance and switching patterns in ACS patients prescribed ticagrelor and aspirin. Secondly, we evaluated the impact of a pilot strategy of close surveillance telephone calls. |
| 520 ## - SUMMARY, ETC. |
|---|
| Abstract |
CONCLUSION: Noncompliance and switching medications are still common for patients who undergo PCI for ACS. A close surveillance program identified patients at risk for medication cessation or switching and could potentially mitigate this phenomenon and improve quality of care. Copyright © 2022. Published by Elsevier Inc. |
| 520 ## - SUMMARY, ETC. |
|---|
| Abstract |
METHODS: The study enrolled 150 consecutive ACS patients who underwent PCI and were prescribed DAPT (aspirin and ticagrelor). This cohort, the "close surveillance arm," then received telephone calls from a healthcare professional to inquire about DAPT for up to one year. These findings, and clinical outcomes, were then compared to a "historical arm" of ACS patients (n = 505) who received PCI and were prescribed DAPT before initiation of the program. Finally, healthcare providers were surveyed about their experience with prescribing DAPT. |
| 520 ## - SUMMARY, ETC. |
|---|
| Abstract |
RESULTS: The rate of ticagrelor cessation trended lower in the close surveillance arm (22.00 % versus 31.70 %, p = 0.0783). The most common reasons for ticagrelor cessation were adverse medication reaction (dyspnea), bleeding, and financial burden. Nevertheless, the adverse events were few and similar between the two groups during follow-up. Over 96 % of healthcare providers surveyed stated that they worry about their patients' DAPT compliance post-PCI. |
| 546 ## - LANGUAGE NOTE |
|---|
| Language note |
English |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
IN PROCESS -- NOT YET INDEXED |
| 651 ## - SUBJECT ADDED ENTRY--GEOGRAPHIC NAME |
|---|
| Institution |
MedStar Heart & Vascular Institute |
| 657 ## - INDEX TERM--FUNCTION |
|---|
| Medline publication type |
Journal Article |
| 700 ## - ADDED ENTRY--PERSONAL NAME |
|---|
| Local Authors |
Abramowitz, Jonathan |
| 700 ## - ADDED ENTRY--PERSONAL NAME |
|---|
| Local Authors |
Ben-Dor, Itsik |
| Institution Code |
MHVI |
| 700 ## - ADDED ENTRY--PERSONAL NAME |
|---|
| Local Authors |
Bernardo, Nelson |
| Institution Code |
MHVI |
| 700 ## - ADDED ENTRY--PERSONAL NAME |
|---|
| Local Authors |
Case, Brian C |
| Institution Code |
MHVI |
| 700 ## - ADDED ENTRY--PERSONAL NAME |
|---|
| Local Authors |
Deksissa, Teshome |
| Institution Code |
MHVI |
| 700 ## - ADDED ENTRY--PERSONAL NAME |
|---|
| Local Authors |
Hashim, Hayder |
| Institution Code |
MHVI |
| 700 ## - ADDED ENTRY--PERSONAL NAME |
|---|
| Local Authors |
Rogers, Toby |
| Institution Code |
MHVI |
| 700 ## - ADDED ENTRY--PERSONAL NAME |
|---|
| Local Authors |
Satler, Lowell |
| Institution Code |
MHVI |
| 700 ## - ADDED ENTRY--PERSONAL NAME |
|---|
| Local Authors |
Shea, Corey |
| Institution Code |
MHVI |
| 700 ## - ADDED ENTRY--PERSONAL NAME |
|---|
| Local Authors |
Sutton, Joseph A |
| Institution Code |
MHVI |
| 700 ## - ADDED ENTRY--PERSONAL NAME |
|---|
| Local Authors |
Torguson, Rebecca |
| Institution Code |
MHVI |
| 700 ## - ADDED ENTRY--PERSONAL NAME |
|---|
| Local Authors |
Waksman, Ron |
| Institution Code |
MHVI |
| 700 ## - ADDED ENTRY--PERSONAL NAME |
|---|
| Local Authors |
Zhang, Cheng |
| Institution Code |
MHVI |
| 790 ## - Authors |
|---|
| All authors |
Abramowitz J, Ben-Dor I, Bernardo NL, Case BC, Deksissa T, Hashim H, Rogers T, Satler LF, Shea C, Sutton JA, Torguson R, Waksman R, Zhang C |
| 856 ## - ELECTRONIC LOCATION AND ACCESS |
|---|
| DOI |
<a href="https://dx.doi.org/10.1016/j.carrev.2022.10.007">https://dx.doi.org/10.1016/j.carrev.2022.10.007</a> |
| Public note |
https://dx.doi.org/10.1016/j.carrev.2022.10.007 |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Koha item type |
Journal Article |
| Item type description |
Article |
